Resistance of the dopamine D2(L) receptor to desensitization accompanies the up-regulation of receptors on to the surface of Sf9 cells

Endocrinology

Volumn 138, Issue 10, 1997, Pages 4199-4206

  Ng, Gordon Y K ^b,d   Varghese, George ^a   Chung, Hans T ^a   Trogadis, Judy ^c   Seeman, Philip ^b   O'Dowd, Brian F ^a,c   George, Susan R ^a,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c TORONTO WESTERN HOSPITAL   (Canada)

^d MERCK FROSST CENTRE FOR THERAPEUTIC RESEARCH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE 2 RECEPTOR; CELL SURFACE RECEPTOR; CYCLOHEXIMIDE; DOPAMINE; FORSKOLIN; MESSENGER RNA; PROTEIN SYNTHESIS INHIBITOR;

ARTICLE; CELL FRACTIONATION; CELL SURFACE; HUMAN; IMMUNOBLOTTING; INSECT; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; ANIMAL; ARMYWORM; CELL LINE; CELL MEMBRANE; CHEMISTRY; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; FEMALE; GENE EXPRESSION REGULATION; GENETICS; IMMUNOHISTOCHEMISTRY; MOTH; OVARY; PHYSIOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN BINDING; UPREGULATION;

ANIMALS; CELL FRACTIONATION; CELL LINE; CELL MEMBRANE; CYCLOHEXIMIDE; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; FORSKOLIN; GENE EXPRESSION REGULATION; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MOTHS; OVARY; PROTEIN BINDING; PROTEIN SYNTHESIS INHIBITORS; RECEPTORS, CELL SURFACE; RECEPTORS, DOPAMINE D2; RNA, MESSENGER; SPODOPTERA; UP-REGULATION;

EID: 85047676970     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.138.10.5433     Document Type: Article

References (38)

1. O'Dowd BF 1993 Structures of dopamine receptors. J Neurochem 60:804-816
2. Ng D, George SR 1992 Pituitary adenomas. Contemp Oncol 1:4-10
3. Florio T, Pan MG, Newman B, Hershberger RE, Civelli O, Stork PJ 1992 Dopaminergic inhibition of DNA synthesis in pituitary tumor cells is associated with phosphotyrosine phosphatase activity. J Biol Chem 267:24169-24172
4. Senogles SE 1994 The D2 dopamine receptor mediates inhibition of growth in GH4ZR7 cells: involvement of protein kinase-C epsilon. Endocrinology 134:783-789
5. Ng GYK, Mouillac B, George SR, Caron M, Dennis M, Bouvier M, O'Dowd BF 1994 Desensitization, phosphorylation and palmitoylation of the human dopamine D1 receptor. Eur J Pharmacol Mol Pharmacol Sec 267:7-19
6. Barton AC, Sibley DR 1990 Agonist-induced desensitization of D1 dopamine receptors linked to adenylyl cyclase activity in cultured NS20Y neuroblastoma cells. Mol Pharmacol 38:531-541
7. Bates MD, Caron MG, Raymond JR 1991 Desensitization of DA1 dopamine receptors coupled to adenylyl cyclase in opossum kidney cells. Am J Physiol 260:F937-F945
8. Ng GYK, Trogadis J, Stevens J, Bouvier M, O'Dowd BF, George SR 1995 Agonist-induced desensitization of dopamine D1 receptor-stimulated adenylyl cyclase activity is temporally and biochemically separated from D1 receptor internalization. Proc Natl Acad Sci USA 92:10157-10161
9. Barton AC, Black LE, Sibley DR 1991 Agonist-induced desensitization of D2 dopamine receptors in human Y-79 retinoblastomal cells. Mol Pharmacol 39:650-658
10. L dopamine receptor isoforms are differentially regulated in Chinese hamster ovary cells. Mol Pharmacol 45:878-889
11. Starr S, Kozell LB, Neve KA 1995 Drug-induced up-regulation of dopamine D2 receptors on cultured cells. J Neurochem 65:569-577
12. Ivins KJ, Luedtke RR, Artymyshyn RP, Molinoff PB 1991 Regulation of dopamine D2 receptors in a novel cell line (SUP1). Mol Pharmacol 39:531-539
13. Filtz TM, Artymyshyn RP, Guan W, Molinoff PB 1993 Paradoxical regulation of dopamine receptors in transfected 293 cells. Mol Pharmacol 44:371-379
14. Itokawa M, Toru M, Ito K, Tsuga H, Kameyama K, Haga T, Arinami T, Hamaguchi H 1996 Sequestration of the short and long isoforms of dopamine D2 receptors expressed in Chinese hamster ovary cells. Mol Pharmacol 49:560-566
15. Ng GYK, O'Dowd BF, Caron M, Dennis M, Brann MR, George SR 1994 Phosphorylation and palmitoylation of the human D2L dopamine receptor in Sf9 cells. J Neurochem 63:1589-1595
16. Boundy VA, Lu L, Molinoff PB 1996 Differential coupling of rat D2 dopamine receptor isoforms expressed in Spodoptera frugipenlci insect cells. J Pharmacol Exp Ther 276:784-794
17. Boundy VA, Pacheco MA, Guan W, Molinoff PB 1996 Agonists and antagonists differentially regulate the high affinity state of the D2L receptor in human embryonic kidney 293 cells. Mol Pharmacol 48:956-964
18. Waldo GL, Northup JK, Perkins JP, Harden TK 1983 Characterization of an altered membrane form of the β-adrenergic receptor produced during agonist induced desensitization. J Biol Chem 258:13900-13908
19. Hertel C, Staehelin M, Perkins JP 1983 Evidence for intravesicular β-adrenergic receptors in membrane fractions from desensitized cells: binding of the hydrophilic ligand CGP-12177 only in the presence of alamethicin. J Cyclic Nucleotide Protein Phosphor Res 9:119-128
20. 2-adrenergic receptor desensitization: delineation with specific inhibitors. J Biol Chem 265:3202-3209
21. Ng GYK, O'Dowd BF, Lee SP, Chung HT, Brann MR, Seeman P, George SR 1996 Dopamine D2 receptor dimers and receptor-blocking peptides. Biochem Biophys Res Commun 227:200-204
22. 2-adrenergic receptor transmembrane domain inhibits both receptor dimerization and activation. J Biol Chem 271:16384-16392
23. 3 results from ligand-induced stabilization. J Biol Chem 267:20082-20086
24. 3-1 cells is associated with unchanged receptor messenger RNA (mRNA) levels and altered mRNA activity. Mol Endocrinol 7:1625-1633
25. Clapham DE, Neer EJ 1993 New roles for C-protein βγ-dimers in transmembrane signalling. Nature 365:403-406
26. Von Zastrow MV, Link R, Daunt D, Barsh G, Kobilka BK 1993 Subtype-specific differences in the intracellular sorting of G protein-coupled receptors. J Biol Chem 268:763-766
27. Cox BA, Rosser MP, Kozlowski MR, Duwe KM, Neve RL, Neve KA 1995 Regulation and functional characterization of a rat recombinant dopamine D3 receptor. Synapse 21:1-9
28. Wang H, Berrios M, Malbon CC 1989 Indirect immunofluorescence localization of beta-adrenergic receptors and G-proteins in human A431 cells. Biochem J 263:519-532
29. 2 receptor stimulation. Mol Pharmacol 43:349-355
30. Collins S, Caron MG, Lefkowitz RJ 1992 From ligand binding to gene expression: new insights into the regulation of G-protein-coupled receptors. Trends Biochem Sci 17:37-39
31. 3-adrenergic receptor expression via multiple cAMP response elements. Proc Natl Acad Sci USA 89:4490-4494
32. Montmayeur JP, Guiramand J, Borrelli E 1993 Preferential coupling between dopamine D2 receptors and G-proteins. Mol Endocrinol 7:161-170
33. Aridor M, Rajmilevich G, Beaven MA, Sagi-Eisenberg R 1993 Activation of exocytosis by the heterotrimeric G protein Gi3. Science 262:1569-1572
34. Milligan G 1993 Agonist regulation of cellular G protein levels and distribution: mechanisms and functional implications. Trend Pharmacol Sci 14:413-418
35. 3H]spiperone binding in vivo in rat brain. J Recept Res 11:163-175
36. Lee TH, Ellinwood Jr EH, Nishita JK 1988 Dopamine receptor sensitivity changes with chronic stimulants. Ann NY Acad Sci 537:324-329
37. Rouillard C, Bedard PJ, Falardeau P, Di Paolo T 1987 Behavioral and biochemical evidence for a different effect of repeated administration of L-dopa and bromocriptine on denervated vs. non-denervated striatal dopamine receptors. Neuropharmacology 26:1601-1606
38. Vassout A, Bruinink A, Krauss J, Waldmeier P, Bischoff S 1993 Regulation of dopamine receptors by bupropion: comparison with antidepressants and CNS stimulants. J Recept Res 13:341-354